UC Davis Veterinary Clinical Trials

A multi-disciplinary, minimally-invasive treatment for nasolacrimal apparatus (NLA) blockage

Help us assess a new treatment that's less invasive for NLA blockages!

Tears from the ocular surface are drained from the eye through several important structures collectively known as the nasolacrimal apparatus (NLA). This frequently becomes blocked and sometimes infected leading to discomfort, tear staining, eye discharge, and skin inflammation, all of which are associated with a decreased quality of life. Clinically, NLA obstructions can be very frustrating to treat and can often lead to permanent obstruction. We have established a team at the UC Davis Veterinary Medical Teaching Hospital consisting of specialists with expertise in Ophthalmology, Internal Medicine, Endoscopy, Diagnostic Imaging, and Interventional Radiology and have utilized fluoroscopy to successfully treat NLA obstruction in dogs. We have utilized fluoroscopy, CT, and endoscopy and capitalized on improvements in instrumentation and minimally invasive techniques developed for catheterization of other challenging locations such as the ureters to successfully treat NLA obstruction. Based upon the success of this initial pilot study, we have initiated a clinical trial to recruit and treat more cases and to evaluate more objective outcome measures.

Device
Any, age None specified

Understanding the genes behind dry eye syndrome in West Highland white terriers

Help us find out what genes cause dry eye syndrome (keratoconjunctivitis sicca) in westies!

Keratoconjunctivitis sicca (KCS) or dry eye is a devastating disease that causes ocular pain and potentially blindness. It is seen more frequently in West Highland White Terriers in comparison to many other breeds. We are interested identifying the genetic components of this disease as well as characterizing this disease better with examination and testing of the tear film and ocular surface and in select patients using advanced imaging techniques.

Other - Genetic Study
Any, age Multiple

Understanding Corneal Endothelial Dystrophy in Boston Terriers, German Shorthaired and Wirehaired Pointers

Help us find out what genes cause corneal endothelial dystrophy in different breeds!

Corneal endothelial dystrophy (CED) is a devastating disease in dogs that can result in blindness and severe ocular pain from secondary complications. The endothelial cells comprise the most inner aspect of the cornea and are responsible for maintaining a proper fluid balance. This function is critical to ensuring that the cornea remains transparent for vision. In many animals, including dogs, corneal endothelial cells have a very limited capacity to regenerate following injury. In canine patients with CED, the endothelial cells degenerate until the cells still remaining can no longer function properly. This results in swelling of the cornea (edema) which results in decreased vision as well as formation of small fluid-filled blisters (bullae) on the cornea which can rupture and cause ocular discomfort. There are palliative treatments such as hypertonic saline to decrease corneal bullae formation but the only definitive treatment for this condition is a corneal transplant (penetrating keratoplasty). Unfortunately, corneal transplants are rarely performed in canine patients with CED due to the expense of the surgery and follow-up care, relatively high risk of complications, and lack of appropriate donor tissue. Several dog breeds, including Boston Terriers, German Shorthaired Pointers and German Wirehaired Pointers, are seen more commonly for CED in comparison to other breeds. This observation suggests that this disease may have a genetic component. A similar condition called Fuch’s endothelial corneal dystrophy (FECD) exists in humans and several genes associated with FECD have been identified. We propose to identify the region of the dog genome associated with CED in Boston Terriers, German Shorthaired Pointers and German Wirehaired Pointers. In order to do this, we will perform thorough eye examinations and use non-invasive advanced imaging techniques to examine Boston Terriers, German Shorthaired Pointers and German Wirehaired Pointers with CED and age-matched control dogs. We will collect blood from these dogs to obtain DNA. The entire canine genome will be evaluated for an association with CED. This work will be used to identify the gene(s) responsible for this condition in Boston Terriers, German Shorthaired Pointers and German Wirehaired Pointers. The ultimate goal will be to develop a genetic test for CED in Boston Terriers, German Shorthaired Pointers and German Wirehaired Pointers and possibly other breeds, such as Chihuahuas and Dachshunds, with an increased risk of CED.

Genetic Study

Understanding the genetics causing ocular squamous cell carcinoma in horses

Help us find out what genes cause ocular squamous cell carcinoma in horses!

Squamous cell carcinoma (SCC) is one of the most common forms of cancer to affect the eye in horses, frequently occurring at the limbus, where the clear cornea meets the white of the eye, or on the nictitating membrane, also known as the third eyelid. This type of eye cancer affects some breeds more than others (e.g., Haflingers) so the objective of this study is to determine the role genetics plays in ocular squamous cell carcinoma in multiple breeds. This study is designed to determine the incidence of SCC, to determine the modes of inheritance and identify DNA variants that put horses at risk for this cancer.

Genetic Study
Loading